Sarcopenia, a condition shared by various diseases: can we alleviate or delay the progression?

Area of Science:

• Gerontology
• Molecular Biology
• Clinical Medicine

Background:

• Sarcopenia is a significant health issue associated with chronic diseases, characterized by complex, not fully understood molecular mechanisms.
• Research is limited by a lack of suitable animal models and universally accepted clinical definitions and diagnostic criteria for sarcopenia.
• These limitations impede accurate prevalence assessment and the development of effective therapeutic and preventive strategies.

Purpose of the Study:

• To provide an overview of the principal molecular pathways involved in sarcopenia.
• To critically examine various potential interventions for sarcopenia.
• To highlight challenges in sarcopenia research and clinical practice.

Main Methods:

• Literature review of sarcopenia research.
• Analysis of molecular mechanisms underlying muscle loss.
• Evaluation of current and emerging therapeutic strategies.

Main Results:

• Identification of key molecular pathways implicated in sarcopenia.
• Discussion of limitations in current diagnostic and research methodologies.
• Overview of lifestyle and pharmacological interventions.

Conclusions:

• Sarcopenia is a complex condition requiring further research into its molecular underpinnings.
• Standardized definitions and improved animal models are crucial for advancing sarcopenia research.
• Emerging interventions, alongside lifestyle modifications, show promise for managing sarcopenia.